NIR‐Light‐Triggered Mild‐Temperature Hyperthermia to Overcome the Cascade Cisplatin Resistance for Improved Resistant Tumor Therapy
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202303667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Mingmao Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350108, China. Hauptthemen laut MEDLINE: Cisplatin, Drug Resistance, Neoplasm, Hyperthermia, Induced, Indoles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, Fuzhou University Testing Fund of Precious Apparatus.
Abstract (Originalsprache)
Currently, cisplatin resistance has been recognized as a multistep cascade process for its clinical chemotherapy failure. Hitherto, it remains challenging to develop a feasible and promising strategy to overcome the cascade drug resistance (CDR) issue for achieving fundamentally improved chemotherapeutic efficacy. Herein, a novel self‐assembled nanoagent is proposed, which is constructed by Pt(IV) prodrug, cyanine dye (cypate), and gadolinium ion (Gd 3+ ), for systematically conquering the cisplatin resistance by employing near‐infrared (NIR) light activated mild‐temperature hyperthermia in tumor targets. The proposed nanoagents exhibit high photostability, GSH/H + ‐responsive dissociation, preferable photothermal conversion, and enhanced cellular uptake performance. In particular, upon 785‐nm NIR light irradiation, the generated mild temperature of ≈ 43 °C overtly improves the cell membrane permeability and drug uptake, accelerates the disruption of intracellular redox balance, and apparently enhances the formation of Pt‐DNA adducts, thereby effectively overcoming the CDR issue and achieves highly improved therapeutic efficacy for cisplatin‐resistant tumor ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biological Science and Engineering, Fuzhou University, Fuzhou, 350108, China.
- CAS Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Key Laboratory of Nanomaterials, and State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter,…
- MOE Key Laboratory for Analytical Science of Food Safety and Biology, State Key Laboratory of Photocatalysis on Energy and Environment, College of Chemistry, Fuzhou University, Fuzhou, 350108, China.
- Fujian Key Laboratory of Medical Instrument and Pharmaceutical Technology, Fuzhou University, Fuzhou, 350108, China.
ORCID-Profile: Mingmao Chen, Yan Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province
- Fuzhou University Testing Fund of Precious Apparatus
- Open Fund of State Key Laboratory of Structural Chemistry
Zitieren
APA
Chen, M., Fu, Y., Liu, Y., Zhang, B., Song, X., Chen, X., Zhu, Z., Gao, H., Yang, J., & Shi, X. (2024). NIR‐Light‐Triggered Mild‐Temperature Hyperthermia to Overcome the Cascade Cisplatin Resistance for Improved Resistant Tumor Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202303667
Vancouver
Chen M, Fu Y, Liu Y, Zhang B, Song X, Chen X, et al. NIR‐Light‐Triggered Mild‐Temperature Hyperthermia to Overcome the Cascade Cisplatin Resistance for Improved Resistant Tumor Therapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202303667
BibTeX
@article{Chen2024,
author = {Chen, Mingmao and Fu, Yulei and Liu, Yan and Zhang, Baihe and Song, Xiaorong and Chen, Xinchun and Zhu, Zhengjia and Gao, Hang and Yang, Jianmin and Shi, Xianai},
title = {NIR‐Light‐Triggered Mild‐Temperature Hyperthermia to Overcome the Cascade Cisplatin Resistance for Improved Resistant Tumor Therapy},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202303667}
}
EUVIMED